| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |